Hybridization Stocks List

Recent Signals

Date Stock Signal Type
2021-02-26 A 50 DMA Resistance Bearish
2021-02-26 HOLX Calm After Storm Range Contraction
2021-02-26 NEO Stochastic Reached Oversold Weakness
2021-02-26 NEO Lower Bollinger Band Walk Weakness

Recent News for Hybridization Stocks

Date Stock Title
Feb 26 HOLX Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall
Feb 26 HOLX Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates
Feb 26 HOLX LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss
Feb 26 NEO NeoGenomics, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 26 HOLX NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines
Feb 25 NEO NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
Feb 25 HOLX iCAD (ICAD) Q4 2020 Earnings Call Transcript
Feb 24 NEO NeoGenomics (NEO) CEO Doug VanOort on Q4 2020 Results - Earnings Call Transcript
Feb 24 NEO Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript
Feb 24 NEO The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 24 NEO NeoGenomics announces CEO succession
Feb 24 NEO NeoGenomics EPS beats by $0.08, beats on revenue
Feb 24 NEO NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter
Feb 24 NEO NeoGenomics Announces CEO Succession
Feb 24 NEO NeoGenomics, Inc. to Host Earnings Call
Feb 24 NEO Is NeoGenomics, Inc. (NASDAQ:NEO) Expensive For A Reason? A Look At Its Intrinsic Value
Feb 23 NEO NeoGenomics Q4 2020 Earnings Preview
Feb 22 HOLX Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market
Feb 22 A Agilent’s pharmDx assay approved for use in non-small cell lung cancer
Feb 22 A Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)